According to Fortune Business Insights, the global AI in clinical trials market size was valued at USD 3.8 billion in 2025 and is projected to grow from USD 5.5 billion in 2026 to USD 77.30 billion by 2034, exhibiting a CAGR of 39.14% during the forecast period. North America dominated the AI in clinical trials market with a market share of 52.26% in 2025.
The market is gaining momentum as pharmaceutical companies, biotechnology firms, contract research organizations, and healthcare institutions increasingly adopt artificial intelligence to improve the efficiency of clinical research. AI technologies help researchers analyze large datasets, identify suitable participants, optimize trial protocols, and monitor patient responses. These capabilities support faster decision-making and help address operational challenges associated with clinical trials. The growing complexity of drug development and the demand for more efficient research processes are encouraging organizations to integrate AI-driven solutions into their clinical development workflows.
Continue reading for more details:
https://www.fortunebusinessinsights.com/ai-in-clinical-trials-market-114081
The AI in clinical trials market can be segmented based on component, application, deployment, end user, and therapeutic area. By component, the market includes software and services. AI software supports data analysis, patient recruitment, trial design, predictive modeling, and clinical data management, while services help research organizations implement, integrate, and maintain AI-based platforms. Software adoption is supported by the need to automate repetitive tasks and improve the management of complex clinical datasets. Services remain important for organizations seeking specialized technical expertise and assistance with integrating artificial intelligence into existing research systems.
Based on application, the market covers patient recruitment and enrollment, clinical trial design and optimization, data management, patient monitoring, safety assessment, and other research activities. AI-powered recruitment tools can analyze patient records and clinical information to identify individuals who may qualify for specific studies. Predictive analytics can help researchers assess enrollment feasibility, anticipate potential delays, and improve trial planning. In data management, machine learning and natural language processing support the extraction, organization, and interpretation of information from multiple sources. AI-based monitoring tools can also help identify unusual patterns in patient data and support the timely review of potential safety concerns.
By deployment, the market includes cloud-based and on-premises solutions. Cloud-based platforms offer scalability, remote accessibility, and flexible data processing capabilities, making them useful for research programs involving multiple locations. On-premises solutions appeal to organizations that prefer greater direct control over their IT infrastructure and sensitive clinical information. By end user, the market includes pharmaceutical and biotechnology companies, contract research organizations, academic and research institutions, and other healthcare stakeholders. Pharmaceutical companies and contract research organizations are important users because they manage extensive clinical development programs and seek technologies that improve research productivity.